Clinical Trial Update: A Study to Evaluate ICP-022 in Patients With CLL/ SLL [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on ICP-022 for chronic lymphocytic leukemia and small lymphocytic lymphoma (early-phase study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• ICP-022

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: CLL/SLL | Phase 1, Phase 2 | Status: UNKNOWN